Depo Provera Lawsuit News

Neurologists Say That There Has Been An Increase In The Number Of Meningioma Diagnoses Among Depo-Provera Patients

More and more women who have been on Depo-Provera for a long time are getting brain tumors, which raises new questions about the safety of the birth control

Tuesday, August 12, 2025 - Neurologists all throughout the country are sounding the alarm about what they say is a clear rise in meningioma diagnoses among patients who have been on Depo-Provera for a long time. Many people have thought for a long time that this injectable birth control method, which is given every three months, is a good and easy way to prevent pregnancy. But new trends in neurological clinics suggest that using them for a long time may increase the risk of getting meningiomas, which are tumors that grow in the membranes that surround the brain and spinal cord. These tumors are usually not cancerous, but when they are, they can cause major problems like seizures, eyesight loss, and memory loss. A lot of women who have been harmed are now talking to a Depo-Provera brain tumor lawyer to find out if they may file a Depo-Provera cancer case, saying that they were never told about these possible risks. Patient advocates believe that the rise in diagnoses shows how important it is for women who have been on the medicine for a long time to be more attentive and get screened sooner, especially since symptoms can be hard to notice until the tumor has grown a lot.

The U.S. Food and Drug Administration (FDA) says that recent postmarket safety studies and clinical data have demonstrated a statistically significant link between long-term use of Depo-Provera and a higher risk of developing meningiomas. The agency looked at several studies that show the risk seems to go up a lot after five years of continuous usage, which suggests a dose-duration link. Neurologists who are reporting the increase are telling healthcare professionals to talk about the danger of meningioma during contraceptive counseling sessions, especially with patients who are thinking about using Depo-Provera as a long-term alternative. A lot of people are also suggesting that long-term users who start to have headaches, blurry vision, or memory problems get regular neurological exams and, in some cases, MRI scans. People who disagree say that these safety precautions should have been put in place years ago, referring to past international research that suggested similar hazards. The rise in diagnoses has also led to arguments about whether drug firms and regulators moved swiftly enough to change prescribing recommendations and labels. As more neurologists speak out about the trend, the medical profession is under growing pressure to rethink Depo-Provera's position in long-term contraception and give patients better, more complete information about the risks.

If this tendency keeps up, Depo-Provera's future as a long-term birth control method could be very different. More medical inspection might mean shorter advised use times, required risk counseling, and maybe even routine brain scans for those with a high risk of problems. These modifications might help find problems earlier, which could stop serious problems from happening and cut down on the need for intrusive surgeries.

More Recent Depo Provera Lawsuit News:

Depo Provera Brain Tumor Attorneys Handling Claims Nationwide

We will represent all persons involved in a Depo Provera lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who has been treated for a meningioma brain tumor and has a history of using Depo Provera for at least a year--or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Depo Provera meningioma lawyers will contact you promptly to discuss your case.



Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.